{
    "id": "979b013a-69e1-4d12-8ea7-4c36af9e833b",
    "indications": "Trospium Chloride Tablets are a muscarinic antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.",
    "contraindications": "The recommended dose is 20 mg twice daily. Trospium Chloride Tablets should be dosed at least one hour before meals or given on an empty stomach.\n                  Dosage modification is recommended in the following patient populations:\n                  \n                     \n                        •For patients with severe renal impairment (creatinine clearance < 30 mL/min), the recommended dose is 20 mg once daily at bedtime [see \n                        \n                           WARNINGS AND PRECAUTIONS (5.5), USE IN SPECIFIC POPULATIONS (8.6), \n                        and \n                        \n                           CLINICAL PHARMACOLOGY (12.3)\n                        ].\n                     \n                        •In geriatric patients ≥ 75 years of age, dose may be titrated down to 20 mg once daily based upon tolerability [see \n                        \n                           USE IN SPECIFIC POPULATIONS (8.5)\n                        ].",
    "warningsAndPrecautions": "Trospium Chloride Tablets 20 mg (white, round, standard cup film coated tablet, debossed with 'PAD' on one side and '145' on the other side) are supplied as follows:\n                  60 count in a Bottle - NDC 63629-9279-1\n                  Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].\n                  Repackaged/Relabeled by:\n                  Bryant Ranch Prepack, Inc.\n                  Burbank, CA 91504",
    "adverseReactions": "Trospium Chloride Tablets are contraindicated in patients with:\n                  \n                     \n                        •urinary retention\n                     \n                        •gastric retention\n                     \n                        •uncontrolled narrow-angle glaucoma.\n                     \n                        •known hypersensitivity to the drug or its ingredients. Angioedema, rash and anaphylactic reaction have been reported.",
    "ingredients": [
        {
            "name": "TROSPIUM CHLORIDE",
            "code": "1E6682427E"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "CALCIUM CARBONATE",
            "code": "H0G9379FGK"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        }
    ],
    "organization": "Bryant Ranch Prepack",
    "name": "TROSPIUM CHLORIDE",
    "effectiveTime": "20231023"
}